TSC Ratings' Updates: Whirlpool

AstraZeneca has reported somewhat volatile earnings recently. However, we feel it is poised for earnings-per-share (EPS) growth in the coming year. During the past fiscal year, AstraZeneca reported lower earnings of $3.73 a share, vs. $3.85 in the prior year. This year, the market expects an improvement in earnings ($4.43 a share vs. $3.73). AstraZeneca had been rated hold since February 2008.

Next up is Minas Buenaventura (BVN Quote), which is downgraded to hold. The company engages in the exploration, mining and processing of gold, silver, and various metals in Peru and internationally.

Over the same quarter one year prior, revenue rose by 37.5%. The gross profit margin for Minas is currently very high, coming in at 70%. Regardless of the strong results of the gross profit margin, the net profit margin of -28% is in-line with the industry average. The current debt-to-equity ratio, 0.36, is low and falls below the industry average, implying successful management of debt levels. Although the company had a strong debt-to-equity ratio, its quick ratio of 0.75 is somewhat weak and could be cause for future problems.